Do analysts prefer SYRA or SPPL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Simpple 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, SYRA or SPPL?

Syra Health has higher revenue and earnings than Simpple. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Syra Health $7.98M 0.97 -$2.94M -$0.02 N/A Simpple $4.59M 4.48 -$3.26M N/A N/A

Is SYRA or SPPL more profitable?

Simpple has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Simpple's return on equity of 0.00% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets Syra Health -54.90% -131.94% -99.19% Simpple N/A N/A N/A

Do analysts prefer SGRP or SYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SPAR Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is SGRP or SYRA more profitable?

SPAR Group has a net margin of -18.51% compared to Syra Health's net margin of -54.90%. SPAR Group's return on equity of -107.74% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets SPAR Group -18.51% -107.74% -19.90% Syra Health -54.90% -131.94% -99.19%

Does the media refer more to SGRP or SYRA?

In the previous week, SPAR Group had 6 more articles in the media than Syra Health. MarketBeat recorded 7 mentions for SPAR Group and 1 mentions for Syra Health. SPAR Group's average media sentiment score of 0.10 beat Syra Health's score of 0.00 indicating that SPAR Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SPAR Group 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Syra Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate MGIH or SYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Millennium Group International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings & valuation, MGIH or SYRA?

Syra Health has lower revenue, but higher earnings than Millennium Group International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Millennium Group International $25.33M 0.69 -$6.32M N/A N/A Syra Health $7.98M 0.97 -$2.94M -$0.02 N/A

Do analysts rate TULP or SYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lendway 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is TULP or SYRA more profitable?

Lendway has a net margin of -9.79% compared to Syra Health's net margin of -54.90%. Lendway's return on equity of -42.76% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets Lendway -9.79% -42.76% -4.77% Syra Health -54.90% -131.94% -99.19%

Syra Health (SYRA) Competitors

$0.56 +0.05 (+8.74%)

As of 03:42 PM Eastern

Compare

SYRA vs. SPPL, SGRP, MGIH, TULP, and WHLM

Should you buy Syra Health stock or one of its competitors? MarketBeat compares Syra Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Syra Health include Simpple (SPPL), SPAR Group (SGRP), Millennium Group International (MGIH), Lendway (TULP), and Wilhelmina International (WHLM). These companies are all part of the "business services" industry.

How does Syra Health compare to Simpple?

Syra Health (NASDAQ:SYRA) and Simpple (NASDAQ:SPPL) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Simpple	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Syra Health has higher revenue and earnings than Simpple.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	0.97	-$2.94M	-$0.02	N/A
Simpple	$4.59M	4.48	-$3.26M	N/A	N/A

Simpple has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Simpple's return on equity of 0.00% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
Simpple	N/A	N/A	N/A

4.8% of Syra Health shares are owned by institutional investors. Comparatively, 0.0% of Simpple shares are owned by institutional investors. 36.5% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Syra Health has a beta of 3.08, suggesting that its stock price is 208% more volatile than the broader market. Comparatively, Simpple has a beta of 4.43, suggesting that its stock price is 343% more volatile than the broader market.

In the previous week, Syra Health and Syra Health both had 1 articles in the media. Simpple's average media sentiment score of 1.87 beat Syra Health's score of 0.00 indicating that Simpple is being referred to more favorably in the news media.

Company	Overall Sentiment
Syra Health	Neutral
Simpple	Very Positive

Summary

Simpple beats Syra Health on 7 of the 11 factors compared between the two stocks.

How does Syra Health compare to SPAR Group?

SPAR Group (NASDAQ:SGRP) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

9.6% of SPAR Group shares are held by institutional investors. Comparatively, 4.8% of Syra Health shares are held by institutional investors. 51.5% of SPAR Group shares are held by insiders. Comparatively, 36.5% of Syra Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SPAR Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

SPAR Group has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market. Comparatively, Syra Health has a beta of 3.08, indicating that its share price is 208% more volatile than the broader market.

SPAR Group has a net margin of -18.51% compared to Syra Health's net margin of -54.90%. SPAR Group's return on equity of -107.74% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SPAR Group	-18.51%	-107.74%	-19.90%
Syra Health	-54.90%	-131.94%	-99.19%

In the previous week, SPAR Group had 6 more articles in the media than Syra Health. MarketBeat recorded 7 mentions for SPAR Group and 1 mentions for Syra Health. SPAR Group's average media sentiment score of 0.10 beat Syra Health's score of 0.00 indicating that SPAR Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SPAR Group	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Syra Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Syra Health has lower revenue, but higher earnings than SPAR Group. Syra Health is trading at a lower price-to-earnings ratio than SPAR Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SPAR Group	$136.10M	0.15	-$24.63M	-$1.03	N/A
Syra Health	$7.98M	0.97	-$2.94M	-$0.02	N/A

Summary

SPAR Group beats Syra Health on 10 of the 14 factors compared between the two stocks.

How does Syra Health compare to Millennium Group International?

Millennium Group International (NASDAQ:MGIH) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Millennium Group International has a beta of 0.91, meaning that its stock price is 9% less volatile than the broader market. Comparatively, Syra Health has a beta of 3.08, meaning that its stock price is 208% more volatile than the broader market.

Syra Health has lower revenue, but higher earnings than Millennium Group International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Millennium Group International	$25.33M	0.69	-$6.32M	N/A	N/A
Syra Health	$7.98M	0.97	-$2.94M	-$0.02	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Millennium Group International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Millennium Group International has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Millennium Group International's return on equity of 0.00% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Millennium Group International	N/A	N/A	N/A
Syra Health	-54.90%	-131.94%	-99.19%

In the previous week, Millennium Group International had 1 more articles in the media than Syra Health. MarketBeat recorded 2 mentions for Millennium Group International and 1 mentions for Syra Health. Millennium Group International's average media sentiment score of 1.44 beat Syra Health's score of 0.00 indicating that Millennium Group International is being referred to more favorably in the media.

Company	Overall Sentiment
Millennium Group International	Positive
Syra Health	Neutral

0.3% of Millennium Group International shares are held by institutional investors. Comparatively, 4.8% of Syra Health shares are held by institutional investors. 36.5% of Syra Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Millennium Group International beats Syra Health on 7 of the 12 factors compared between the two stocks.

How does Syra Health compare to Lendway?

Lendway (NASDAQ:TULP) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lendway	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Lendway has a net margin of -9.79% compared to Syra Health's net margin of -54.90%. Lendway's return on equity of -42.76% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lendway	-9.79%	-42.76%	-4.77%
Syra Health	-54.90%	-131.94%	-99.19%

In the previous week, Lendway and Lendway both had 1 articles in the media. Lendway's average media sentiment score of 1.89 beat Syra Health's score of 0.00 indicating that Lendway is being referred to more favorably in the media.

Company	Overall Sentiment
Lendway	Very Positive
Syra Health	Neutral

Lendway has higher earnings, but lower revenue than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than Lendway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lendway	$5.15M	3.48	-$2.85M	-$2.75	N/A
Syra Health	$7.98M	0.97	-$2.94M	-$0.02	N/A

6.6% of Lendway shares are owned by institutional investors. Comparatively, 4.8% of Syra Health shares are owned by institutional investors. 15.4% of Lendway shares are owned by insiders. Comparatively, 36.5% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Lendway has a beta of 2.6, suggesting that its stock price is 160% more volatile than the broader market. Comparatively, Syra Health has a beta of 3.08, suggesting that its stock price is 208% more volatile than the broader market.

Summary

Lendway beats Syra Health on 8 of the 13 factors compared between the two stocks.

How does Syra Health compare to Wilhelmina International?

Wilhelmina International (NASDAQ:WHLM) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

20.0% of Wilhelmina International shares are held by institutional investors. Comparatively, 4.8% of Syra Health shares are held by institutional investors. 49.4% of Wilhelmina International shares are held by company insiders. Comparatively, 36.5% of Syra Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Wilhelmina International has a net margin of 3.38% compared to Syra Health's net margin of -54.90%. Wilhelmina International's return on equity of 2.29% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wilhelmina International	3.38%	2.29%	1.40%
Syra Health	-54.90%	-131.94%	-99.19%

In the previous week, Syra Health had 1 more articles in the media than Wilhelmina International. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Wilhelmina International. Wilhelmina International's average media sentiment score of 0.00 equaled Syra Health'saverage media sentiment score.

Company	Overall Sentiment
Wilhelmina International	Neutral
Syra Health	Neutral

Wilhelmina International has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than Wilhelmina International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wilhelmina International	$17.09M	1.02	$430K	$0.10	27.45
Syra Health	$7.98M	0.97	-$2.94M	-$0.02	N/A

Wilhelmina International has a beta of 0.69, indicating that its share price is 31% less volatile than the broader market. Comparatively, Syra Health has a beta of 3.08, indicating that its share price is 208% more volatile than the broader market.

Summary

Wilhelmina International beats Syra Health on 10 of the 12 factors compared between the two stocks.

Get Syra Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYRA vs. The Competition

Export

Metric	Syra Health	Employment agencies Industry	Medical Sector	NASDAQ Exchange
Market Cap	$7.75M	$16.49M	$6.48B	$12.34B
Dividend Yield	N/A	N/A	2.67%	5.67%
P/E Ratio	-0.86	N/A	23.96	24.58
Price / Sales	0.97	0.63	536.40	168.09
Price / Cash	N/A	N/A	27.48	37.92
Price / Book	0.90	0.61	10.47	6.78
Net Income	-$2.94M	-$13.52M	$3.56B	$337.32M
7 Day Performance	3.70%	2.06%	0.91%	2.01%
1 Month Performance	3.74%	0.01%	1.86%	3.88%
1 Year Performance	N/A	27.01%	25.73%	32.23%

Syra Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYRA Syra Health	N/A	$0.56 +8.7%	N/A	+535.8%	$7.75M	$7.98M	N/A	78	Gap Up High Trading Volume
SPPL Simpple	0.6387 of 5 stars	$3.75 -1.1%	N/A	+34.2%	$21.93M	$4.59M	N/A	34	Positive News
SGRP SPAR Group	1.2017 of 5 stars	$0.84 +7.9%	N/A	-21.3%	$19.60M	$136.10M	N/A	4,522
MGIH Millennium Group International	1.1196 of 5 stars	$1.53 -4.4%	N/A	-6.4%	$18M	$25.33M	N/A	792	Positive News Short Interest Decrease Gap Up
TULP Lendway	0.5731 of 5 stars	$3.61 -1.4%	N/A	N/A	$17.47M	$5.15M	N/A	30	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SYRA) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Syra Health (SYRA) Competitors

SYRA vs. SPPL, SGRP, MGIH, TULP, and WHLM

How does Syra Health compare to Simpple?

Summary

How does Syra Health compare to SPAR Group?

Summary

How does Syra Health compare to Millennium Group International?

Summary

How does Syra Health compare to Lendway?

Summary

How does Syra Health compare to Wilhelmina International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Syra Health (SYRA) Competitors

SYRA vs. SPPL, SGRP, MGIH, TULP, and WHLM

How does Syra Health compare to Simpple?

Do analysts prefer SYRA or SPPL?

Which has preferable valuation and earnings, SYRA or SPPL?

Is SYRA or SPPL more profitable?

Do institutionals & insiders believe in SYRA or SPPL?

Which has more risk & volatility, SYRA or SPPL?

Does the media prefer SYRA or SPPL?

Summary

How does Syra Health compare to SPAR Group?

Do institutionals and insiders have more ownership in SGRP or SYRA?

Do analysts prefer SGRP or SYRA?

Which has more volatility & risk, SGRP or SYRA?

Is SGRP or SYRA more profitable?

Does the media refer more to SGRP or SYRA?

Which has higher valuation & earnings, SGRP or SYRA?

Summary

How does Syra Health compare to Millennium Group International?

Which has more volatility & risk, MGIH or SYRA?

Which has higher earnings & valuation, MGIH or SYRA?

Do analysts rate MGIH or SYRA?

Is MGIH or SYRA more profitable?

Does the media favor MGIH or SYRA?

Do insiders and institutionals hold more shares of MGIH or SYRA?

Summary

How does Syra Health compare to Lendway?

Do analysts rate TULP or SYRA?

Is TULP or SYRA more profitable?

Does the media prefer TULP or SYRA?

Which has preferable earnings and valuation, TULP or SYRA?

Do institutionals and insiders have more ownership in TULP or SYRA?

Which has more risk & volatility, TULP or SYRA?

Summary

How does Syra Health compare to Wilhelmina International?

Do institutionals and insiders have more ownership in WHLM or SYRA?

Is WHLM or SYRA more profitable?

Does the media prefer WHLM or SYRA?

Which has preferable valuation & earnings, WHLM or SYRA?

Which has more risk & volatility, WHLM or SYRA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools